Vorinostat, a histone deacetylase inhibitor, upregulates the expression of multiple tumor suppressor genes, such as CDKN2A and TP53, and induces senescence via these two major pathways in various cancer cell lines [158, 159]. The gene discussed is TP53; the disease is cancer.